Moran Wealth Management LLC Has $14.28 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Moran Wealth Management LLC reduced its position in UnitedHealth Group Incorporated (NYSE:UNH) by 1.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 28,229 shares of the healthcare conglomerate’s stock after selling 488 shares during the quarter. Moran Wealth Management LLC’s holdings in UnitedHealth Group were worth $14,280,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of UNH. Wallace Capital Management Inc. lifted its holdings in UnitedHealth Group by 0.9% in the 3rd quarter. Wallace Capital Management Inc. now owns 2,119 shares of the healthcare conglomerate’s stock worth $1,239,000 after buying an additional 19 shares during the period. Western Pacific Wealth Management LP boosted its holdings in UnitedHealth Group by 2.2% in the fourth quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate’s stock valued at $456,000 after acquiring an additional 19 shares in the last quarter. Paragon Capital Management LLC lifted its position in shares of UnitedHealth Group by 2.9% in the 3rd quarter. Paragon Capital Management LLC now owns 721 shares of the healthcare conglomerate’s stock worth $422,000 after purchasing an additional 20 shares during the period. MCF Advisors LLC increased its position in shares of UnitedHealth Group by 0.8% during the fourth quarter. MCF Advisors LLC now owns 2,578 shares of the healthcare conglomerate’s stock valued at $1,304,000 after buying an additional 20 shares during the period. Finally, Axiom Financial Strategies LLC lifted its holdings in UnitedHealth Group by 3.6% in the fourth quarter. Axiom Financial Strategies LLC now owns 575 shares of the healthcare conglomerate’s stock worth $291,000 after buying an additional 20 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 1.2 %

UnitedHealth Group stock opened at $493.35 on Monday. The stock has a market cap of $451.28 billion, a PE ratio of 31.83, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock has a fifty day moving average of $513.78 and a 200 day moving average of $553.39. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same period in the previous year, the business posted $5.83 earnings per share. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be given a dividend of $2.10 per share. The ex-dividend date is Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 1.70%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.19%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the business’s stock in a transaction dated Friday, January 17th. The shares were purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Company insiders own 0.33% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently commented on UNH shares. Wells Fargo & Company lowered their target price on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Stephens upped their target price on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Oppenheimer boosted their price target on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Finally, HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective for the company in a research note on Friday, January 10th. One research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Buy” and a consensus target price of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.